134 related articles for article (PubMed ID: 15227730)
1. Retinoic acid receptor-beta expression in stage I non-small cell lung cancer and adjacent normal appearing bronchial epithelium.
Chang YS; Chung JH; Shin DH; Chung KY; Kim YS; Chang J; Kim SK; Kim SK
Yonsei Med J; 2004 Jun; 45(3):435-42. PubMed ID: 15227730
[TBL] [Abstract][Full Text] [Related]
2. Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development.
Xu XC; Sozzi G; Lee JS; Lee JJ; Pastorino U; Pilotti S; Kurie JM; Hong WK; Lotan R
J Natl Cancer Inst; 1997 May; 89(9):624-9. PubMed ID: 9150186
[TBL] [Abstract][Full Text] [Related]
3. Retinoid refractoriness occurs during lung carcinogenesis despite functional retinoid receptors.
Kim YH; Dohi DF; Han GR; Zou CP; Oridate N; Walsh GL; Nesbitt JC; Xu XC; Hong WK; Lotan R
Cancer Res; 1995 Dec; 55(23):5603-10. PubMed ID: 7585641
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive expression analysis of retinoic acid receptors and retinoid X receptors in non-small cell lung cancer: implications for tumor development and prognosis.
Brabender J; Metzger R; Salonga D; Danenberg KD; Danenberg PV; Hölscher AH; Schneider PM
Carcinogenesis; 2005 Mar; 26(3):525-30. PubMed ID: 15618235
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer.
Han CH; Cho JY; Moon JT; Kim HJ; Kim SK; Shin DH; Chang J; Ahn CM; Kim SK; Chang YS
Oncol Rep; 2006 Dec; 16(6):1205-10. PubMed ID: 17089038
[TBL] [Abstract][Full Text] [Related]
6. Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized placebo-controlled trial.
Kurie JM; Lotan R; Lee JJ; Lee JS; Morice RC; Liu DD; Xu XC; Khuri FR; Ro JY; Hittelman WN; Walsh GL; Roth JA; Minna JD; Hong WK
J Natl Cancer Inst; 2003 Feb; 95(3):206-14. PubMed ID: 12569142
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid receptor and retinoid X receptor alterations in lung cancer precursor lesions.
Martinet N; Alla F; Farré G; Labib T; Drouot H; Vidili R; Picard E; Gaube MP; Le Faou D; Siat J; Borelly J; Vermylen P; Bazarbachi T; Vignaud JM; Martinet Y
Cancer Res; 2000 Jun; 60(11):2869-75. PubMed ID: 10850430
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer.
Khuri FR; Lotan R; Kemp BL; Lippman SM; Wu H; Feng L; Lee JJ; Cooksley CS; Parr B; Chang E; Walsh GL; Lee JS; Hong WK; Xu XC
J Clin Oncol; 2000 Aug; 18(15):2798-804. PubMed ID: 10920126
[TBL] [Abstract][Full Text] [Related]
9. [Retinoid expression (RARbeta and CRBP1) in non-small-cell lung carcinoma].
Mauro LV; Dalurzo M; Smith D; Lastiri J; Vasallo B; Joffei EB; Pallotta MG; Puricelli L
Medicina (B Aires); 2008; 68(3):205-12. PubMed ID: 18689151
[TBL] [Abstract][Full Text] [Related]
10. Increased phospho-AKT (Ser(473)) expression in bronchial dysplasia: implications for lung cancer prevention studies.
Tsao AS; McDonnell T; Lam S; Putnam JB; Bekele N; Hong WK; Kurie JM
Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):660-4. PubMed ID: 12869408
[TBL] [Abstract][Full Text] [Related]
11. Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer.
Widschwendter M; Berger J; Daxenbichler G; Müller-Holzner E; Widschwendter A; Mayr A; Marth C; Zeimet AG
Cancer Res; 1997 Oct; 57(19):4158-61. PubMed ID: 9331065
[TBL] [Abstract][Full Text] [Related]
12. Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens.
Loo PS; Thomas SC; Nicolson MC; Fyfe MN; Kerr KM
J Thorac Oncol; 2010 Apr; 5(4):442-7. PubMed ID: 20195168
[TBL] [Abstract][Full Text] [Related]
13. Promoter methylation of APC and RAR-β genes as prognostic markers in non-small cell lung cancer (NSCLC).
Feng H; Zhang Z; Qing X; Wang X; Liang C; Liu D
Exp Mol Pathol; 2016 Feb; 100(1):109-13. PubMed ID: 26681652
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR
Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer.
Khuri FR; Wu H; Lee JJ; Kemp BL; Lotan R; Lippman SM; Feng L; Hong WK; Xu XC
Clin Cancer Res; 2001 Apr; 7(4):861-7. PubMed ID: 11309334
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid receptor beta and telomerase catalytic subunit expression in bronchial epithelium of heavy smokers.
Soria JC; Xu X; Liu DD; Lee JJ; Kurie J; Morice RC; Khuri F; Mao L; Hong WK; Lotan R
J Natl Cancer Inst; 2003 Jan; 95(2):165-8. PubMed ID: 12529350
[TBL] [Abstract][Full Text] [Related]
17. A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesis.
Petty WJ; Li N; Biddle A; Bounds R; Nitkin C; Ma Y; Dragnev KH; Freemantle SJ; Dmitrovsky E
J Natl Cancer Inst; 2005 Nov; 97(22):1645-51. PubMed ID: 16288117
[TBL] [Abstract][Full Text] [Related]
18. Growth suppression of transformed human bronchial epithelial cells by all-trans-retinoic acid occurs through specific retinoid receptors.
Ahn MJ; Langenfeld J; Moasser MM; Rusch V; Dmitrovsky E
Oncogene; 1995 Dec; 11(11):2357-64. PubMed ID: 8570187
[TBL] [Abstract][Full Text] [Related]
19. Roles for USF-2 in lung cancer proliferation and bronchial carcinogenesis.
Ocejo-Garcia M; Baokbah TA; Ashurst HL; Cowlishaw D; Soomro I; Coulson JM; Woll PJ
J Pathol; 2005 Jun; 206(2):151-9. PubMed ID: 15856526
[TBL] [Abstract][Full Text] [Related]
20. The loss of retinoic acid receptor alpha, beta and alcohol dehydrogenase3 expression in non-small cell lung cancer.
Inui N; Sasaki S; Suda T; Chida K; Nakamura H
Respirology; 2003 Sep; 8(3):302-9. PubMed ID: 12911822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
